Differential involvement of optineurin in amyotrophic lateral sclerosis with or without SOD1 mutations
Han-Xiang Deng, Eileen H Bigio, Hong Zhai, Faisal Fecto, Kaouther Ajroud, Yong Shi, Jianhua Yan, Manjari Mishra, Senda Ajroud-Driss, Scott Heller, Robert Sufit, Nailah Siddique, Enrico Mugnaini, Teepu Siddique, Han-Xiang Deng, Eileen H Bigio, Hong Zhai, Faisal Fecto, Kaouther Ajroud, Yong Shi, Jianhua Yan, Manjari Mishra, Senda Ajroud-Driss, Scott Heller, Robert Sufit, Nailah Siddique, Enrico Mugnaini, Teepu Siddique
Abstract
Background: Mutations in optineurin have recently been linked to amyotrophic lateral sclerosis (ALS).
Objective: To determine whether optineurin-positive skeinlike inclusions are a common pathologic feature in ALS, including SOD1 -linked ALS.
Design: Clinical case series.
Setting: Academic referral center.
Subjects: We analyzed spinal cord sections from 46 clinically and pathologically diagnosed ALS cases and ALS transgenic mouse models overexpressing ALS-linked SOD1 mutations G93A or L126Z.
Results: We observed optineurin-immunoreactive skeinlike inclusions in all the sporadic ALS and familial ALS cases without SOD1 mutation, but not in cases with SOD1 mutations or in transgenic mice overexpressing the ALS-linked SOD1 mutations G93A or L126Z.
Conclusion: The data from this study provide evidence that optineurin is involved in the pathogenesis of sporadic ALS and non- SOD1 familial ALS, thus supporting the hypothesis that these forms of ALS share a pathway that is distinct from that of SOD1-linked ALS.
Figures
Source: PubMed